Forbes October 19, 2023
Robert Hart

Topline

Food giant Nestlé on Thursday said it was working on products to accompany weight-loss drugs like Ozempic, Wegovy and Mounjaro, as the food industry evolves in response to the soaring popularity of the appetite-killing drugs amid fears they will dampen demand and erode bottom lines.

Key Facts

News Peg

The stellar successes of Wegovy and Ozempic—which have been shown to help facilitate weight loss and could bestow other health benefits in areas like heart and kidney disease—has transformed drugmaker Novo Nordisk into the most valuable public company in Europe. The firm has struggled to keep up with demand and has acknowledged it will take years for it to do so. They are likely the leading edge of an impending...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Retailer
AI, Omnichannel and Social Commerce: Inside the 2024 D2C Transformation
How AI Is Quietly Transforming E-Commerce Search And Discovery
Walmart's '24 healthcare exit: 10 notes
What big retailers did in healthcare in 2024
How Trauma-Informed Design Principles Can Be Health-Ful for All of Us – Learning from IKEA

Share This Article